Business Description
Health Italia SpA
ISIN : IT0005585861
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.38 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.22 | |||||
Debt-to-EBITDA | 1.45 | |||||
Interest Coverage | 8.9 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.97 | |||||
Beneish M-Score | -2.43 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.4 | |||||
3-Year EBITDA Growth Rate | 12 | |||||
3-Year EPS without NRI Growth Rate | -1 | |||||
3-Year FCF Growth Rate | 271.1 | |||||
3-Year Book Growth Rate | 10.6 | |||||
Future 3-5Y Total Revenue Growth Rate | 9.7 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 46.67 | |||||
9-Day RSI | 48.87 | |||||
14-Day RSI | 50.9 | |||||
6-1 Month Momentum % | 15.55 | |||||
12-1 Month Momentum % | 5.77 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.23 | |||||
Quick Ratio | 3.23 | |||||
Cash Ratio | 0.18 | |||||
Days Inventory | 26.42 | |||||
Days Sales Outstanding | 291.14 | |||||
Days Payable | 193.9 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 17.43 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 36.88 | |||||
Operating Margin % | 15.8 | |||||
Net Margin % | 4.51 | |||||
FCF Margin % | 8.27 | |||||
ROE % | 4.76 | |||||
ROA % | 2.52 | |||||
ROIC % | 5.76 | |||||
ROC (Joel Greenblatt) % | 12.97 | |||||
ROCE % | 9.06 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 14.72 | |||||
Forward PE Ratio | 4.76 | |||||
PE Ratio without NRI | 7.77 | |||||
Price-to-Owner-Earnings | 25.79 | |||||
PEG Ratio | 0.86 | |||||
PS Ratio | 0.65 | |||||
PB Ratio | 0.66 | |||||
Price-to-Tangible-Book | 0.73 | |||||
Price-to-Free-Cash-Flow | 7.91 | |||||
Price-to-Operating-Cash-Flow | 6.7 | |||||
EV-to-EBIT | 7 | |||||
EV-to-EBITDA | 5.36 | |||||
EV-to-Revenue | 0.79 | |||||
EV-to-FCF | 9.52 | |||||
Price-to-Projected-FCF | 1.46 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.86 | |||||
Price-to-Graham-Number | 0.5 | |||||
Price-to-Net-Current-Asset-Value | 0.96 | |||||
Earnings Yield (Greenblatt) % | 14.31 | |||||
FCF Yield % | 12.58 | |||||
Forward Rate of Return (Yacktman) % | 13.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Health Italia SpA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 37.42 | ||
EPS (TTM) (€) | 8.797 | ||
Beta | -0.43 | ||
Volatility % | 60.41 | ||
14-Day RSI | 50.9 | ||
14-Day ATR (€) | 5.064413 | ||
20-Day SMA (€) | 129.4 | ||
12-1 Month Momentum % | 5.77 | ||
52-Week Range (€) | 87.2 - 175 | ||
Shares Outstanding (Mil) | 0.19 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Health Italia SpA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Health Italia SpA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Health Italia SpA Frequently Asked Questions
What is Health Italia SpA(MIL:HI)'s stock price today?
When is next earnings date of Health Italia SpA(MIL:HI)?
Does Health Italia SpA(MIL:HI) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |